Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

North America Corrugated Metal Flexible Hoses Market

ID: MRFR/Equip/63813-CR
100 Pages
Pradeep Nandi
Last Updated: April 24, 2026

North America Corrugated Metal Flexible Hoses Market Research Report Information by Type (Braided Metal Hoses (Stainless Steel Braided Hoses, Others Alloy Braided Hoses), Non-Braided Metal Hoses (Stainless Steel Non-Braided Hoses, Other Alloy Non-Braided Hoses)), by Application (Industrial (Chemical Processing, Oil Gas, Automotive, Aerospace Aviation, Food & Beverage, Pharmaceuticals, Others (Steel, Marine)), Commercial (HVAC Systems, Commercial Kitchens, Plumbing Systems), Residential (Water Lines, Gas Lines)), by Manufacturing Process (Welding, Braiding, Forming, Others (Crimping and Cutting)), by Distribution Channel (Direct Sales, Online Sales, Distributors & Dealers) and Country (U.S, Canada) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

North America Corrugated Metal Flexible Hoses Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Application (USD Million)
  49.     4.1.1 Automotive
  50.     4.1.2 Aerospace
  51.     4.1.3 Industrial
  52.     4.1.4 Marine
  53.     4.1.5 Construction
  54.   4.2 Pharmaceutical, BY End Use (USD Million)
  55.     4.2.1 Oil and Gas
  56.     4.2.2 Chemical Processing
  57.     4.2.3 Water Treatment
  58.     4.2.4 Food and Beverage
  59.     4.2.5 Pharmaceutical
  60.   4.3 Pharmaceutical, BY Material Type (USD Million)
  61.     4.3.1 Stainless Steel
  62.     4.3.2 Aluminum
  63.     4.3.3 Copper
  64.     4.3.4 Bronze
  65.     4.3.5 Plastic
  66.   4.4 Pharmaceutical, BY Diameter Size (USD Million)
  67.     4.4.1 Small Diameter
  68.     4.4.2 Medium Diameter
  69.     4.4.3 Large Diameter
  70.     4.4.4 Custom Diameter
  71.   4.5 Pharmaceutical, BY Pressure Rating (USD Million)
  72.     4.5.1 Low Pressure
  73.     4.5.2 Medium Pressure
  74.     4.5.3 High Pressure
  75.     4.5.4 Ultra High Pressure
  76. 5 SECTION V: COMPETITIVE ANALYSIS
  77.   5.1 Competitive Landscape
  78.     5.1.1 Overview
  79.     5.1.2 Competitive Analysis
  80.     5.1.3 Market share Analysis
  81.     5.1.4 Major Growth Strategy in the Pharmaceutical
  82.     5.1.5 Competitive Benchmarking
  83.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  84.     5.1.7 Key developments and growth strategies
  85.       5.1.7.1 New Product Launch/Service Deployment
  86.       5.1.7.2 Merger & Acquisitions
  87.       5.1.7.3 Joint Ventures
  88.     5.1.8 Major Players Financial Matrix
  89.       5.1.8.1 Sales and Operating Income
  90.       5.1.8.2 Major Players R&D Expenditure. 2023
  91.   5.2 Company Profiles
  92.     5.2.1 Parker Hannifin (US)
  93.       5.2.1.1 Financial Overview
  94.       5.2.1.2 Products Offered
  95.       5.2.1.3 Key Developments
  96.       5.2.1.4 SWOT Analysis
  97.       5.2.1.5 Key Strategies
  98.     5.2.2 Swagelok Company (US)
  99.       5.2.2.1 Financial Overview
  100.       5.2.2.2 Products Offered
  101.       5.2.2.3 Key Developments
  102.       5.2.2.4 SWOT Analysis
  103.       5.2.2.5 Key Strategies
  104.     5.2.3 Gates Corporation (US)
  105.       5.2.3.1 Financial Overview
  106.       5.2.3.2 Products Offered
  107.       5.2.3.3 Key Developments
  108.       5.2.3.4 SWOT Analysis
  109.       5.2.3.5 Key Strategies
  110.     5.2.4 Continental AG (DE)
  111.       5.2.4.1 Financial Overview
  112.       5.2.4.2 Products Offered
  113.       5.2.4.3 Key Developments
  114.       5.2.4.4 SWOT Analysis
  115.       5.2.4.5 Key Strategies
  116.     5.2.5 Flexicraft Industries (US)
  117.       5.2.5.1 Financial Overview
  118.       5.2.5.2 Products Offered
  119.       5.2.5.3 Key Developments
  120.       5.2.5.4 SWOT Analysis
  121.       5.2.5.5 Key Strategies
  122.     5.2.6 Metal Hose (US)
  123.       5.2.6.1 Financial Overview
  124.       5.2.6.2 Products Offered
  125.       5.2.6.3 Key Developments
  126.       5.2.6.4 SWOT Analysis
  127.       5.2.6.5 Key Strategies
  128.     5.2.7 Hose Master (US)
  129.       5.2.7.1 Financial Overview
  130.       5.2.7.2 Products Offered
  131.       5.2.7.3 Key Developments
  132.       5.2.7.4 SWOT Analysis
  133.       5.2.7.5 Key Strategies
  134.     5.2.8 Aeroquip (US)
  135.       5.2.8.1 Financial Overview
  136.       5.2.8.2 Products Offered
  137.       5.2.8.3 Key Developments
  138.       5.2.8.4 SWOT Analysis
  139.       5.2.8.5 Key Strategies
  140.     5.2.9 Trelleborg AB (SE)
  141.       5.2.9.1 Financial Overview
  142.       5.2.9.2 Products Offered
  143.       5.2.9.3 Key Developments
  144.       5.2.9.4 SWOT Analysis
  145.       5.2.9.5 Key Strategies
  146.   5.3 Appendix
  147.     5.3.1 References
  148.     5.3.2 Related Reports
  149. 6 LIST OF FIGURES
  150.   6.1 MARKET SYNOPSIS
  151.   6.2 NORTH AMERICA MARKET ANALYSIS BY APPLICATION
  152.   6.3 NORTH AMERICA MARKET ANALYSIS BY END USE
  153.   6.4 NORTH AMERICA MARKET ANALYSIS BY MATERIAL TYPE
  154.   6.5 NORTH AMERICA MARKET ANALYSIS BY DIAMETER SIZE
  155.   6.6 NORTH AMERICA MARKET ANALYSIS BY PRESSURE RATING
  156.   6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL
  157.   6.8 RESEARCH PROCESS OF MRFR
  158.   6.9 DRO ANALYSIS OF PHARMACEUTICAL
  159.   6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  160.   6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  161.   6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  162.   6.13 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
  163.   6.14 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
  164.   6.15 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
  165.   6.16 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
  166.   6.17 PHARMACEUTICAL, BY MATERIAL TYPE, 2024 (% SHARE)
  167.   6.18 PHARMACEUTICAL, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
  168.   6.19 PHARMACEUTICAL, BY DIAMETER SIZE, 2024 (% SHARE)
  169.   6.20 PHARMACEUTICAL, BY DIAMETER SIZE, 2024 TO 2035 (USD Million)
  170.   6.21 PHARMACEUTICAL, BY PRESSURE RATING, 2024 (% SHARE)
  171.   6.22 PHARMACEUTICAL, BY PRESSURE RATING, 2024 TO 2035 (USD Million)
  172.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  173. 7 LIST OF TABLES
  174.   7.1 LIST OF ASSUMPTIONS
  175.     7.1.1
  176.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  177.     7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  178.     7.2.2 BY END USE, 2026-2035 (USD Million)
  179.     7.2.3 BY MATERIAL TYPE, 2026-2035 (USD Million)
  180.     7.2.4 BY DIAMETER SIZE, 2026-2035 (USD Million)
  181.     7.2.5 BY PRESSURE RATING, 2026-2035 (USD Million)
  182.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  183.     7.3.1
  184.   7.4 ACQUISITION/PARTNERSHIP
  185.     7.4.1

North America Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2026-2035)

  • Automotive
  • Aerospace
  • Industrial
  • Marine
  • Construction

Pharmaceutical By End Use (USD Million, 2026-2035)

  • Oil and Gas
  • Chemical Processing
  • Water Treatment
  • Food and Beverage
  • Pharmaceutical

Pharmaceutical By Material Type (USD Million, 2026-2035)

  • Stainless Steel
  • Aluminum
  • Copper
  • Bronze
  • Plastic

Pharmaceutical By Diameter Size (USD Million, 2026-2035)

  • Small Diameter
  • Medium Diameter
  • Large Diameter
  • Custom Diameter

Pharmaceutical By Pressure Rating (USD Million, 2026-2035)

  • Low Pressure
  • Medium Pressure
  • High Pressure
  • Ultra High Pressure

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions